ImmunoGen Inc (IMGN)

[skitahoe]

It's now been over a year since I posted this, and still BT-062 hasn't initiated Phase III. Their appears to be some doubt about IMGN Opting In, as their own drug may compete with this drug in time, and regardless it will cost them substantially to do so. Some are of the belief that Biotest wants a ROW partner regardless before initiating a Phase III Trial. In short, it may be money, not data, that's delaying the initiation of a Phase III Trial.

On other fronts, IMGN now has another of it's drugs in trials and ASCO should reveal more about IMGN853, which could initiate a Registrational Phase II later this year if discussions go well with the FDA. I believe that, and increasing Kadcyla sales, will lead to new highs later this year.

Gary